Publications by authors named "Julia B Wamstad"
Objective: To compare neurocognition and quality-of-life (QoL) in a group of children and adolescents with or without growth hormone deficiency (GHD) following moderate-to-severe traumatic brain injury (TBI).
Study Designs: Thirty-two children and adolescents were recruited from the TBI clinic at a children's hospital. Growth hormone (GH) was measured by both spontaneous overnight testing and following arginine/glucagon stimulation administration.
Objective: To examine the long-term effects of fluconazole prophylaxis in extremely low birth weight infants.
Study Design: Neurodevelopmental status and quality of life of survivors from a randomized, placebo-controlled trial of fluconazole prophylaxis were evaluated at 8 to 10 years of life using the Vineland Adaptive Behavior Scales-II (VABS-II) and the Child Health Questionnaire Parent-Completed Form 28 (CHQ-PF28), respectively.
Results: VABS-II Domain Scores for the fluconazole-treated (n = 21; 9.
Background: Children who sustain traumatic brain injury (TBI) are at risk for developing hypopituitarism, of which growth hormone deficiency (GHD) is the most common manifestation.
Objective: To determine the prevalence of GHD and associated features following TBI among children and adolescents.
Study Design: A total of 32 children and adolescents were recruited from a pediatric TBI clinic.
Primary Objective: This study examines the relationship between scores on the Western Neuro Sensory Stimulation Profile (WNSSP) and therapeutic participation as it relates to rehabilitation readiness (RR) in adolescents with low response following severe traumatic brain injury (TBI).
Research Design: This is a serial observational design using multiple measures of clinical status and participation.
Methods And Procedures: Ten children, mean age 16.